Company: LRHC
Filing Date: 2025-06-03
Form Type: S-1/A
Source: 0001213900-25-050886
Chunk: 31

Company: La Rosa Holdings Corp.
Filing Date: 2025-06-03
Form: S-1/A
Chunk 31
---
 receive proceeds upon exercise of the Incremental Warrants. We intend to use the net proceeds entirely for general corporate purposes, working capital requirements, and other purposes that the Board of Directors deems to be in the best interests of the Company.

<div align='center'>MARKET PRICE OF OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS</div>

Market Information

Our common stock is listed on the Nasdaq Capital Market under the symbol “LRHC.” A description of our common stock is set forth under the heading “Description of Capital Stock,” beginning on page 23 of this prospectus.

The last reported sale price for our common
stock on June 2, 2025, as reported by Nasdaq, was $0.1259 per share.

Holders

As of May 29, 2025, we had 223 record holders
of our common stock issued and outstanding. The number of record holders was determined from the records of our transfer agent and does
not include beneficial owners of common stock whose shares are held in the names of various security brokers, dealers, and registered
clearing agencies.

Transfer Agent and Registrar

Our transfer agent and registrar for our common stock is Vstock Transfer, LLC located at 18 Lafayette Place, Woodmere, NY 11598. Their telephone number is (212) 828-8436.

Dividend Policy

The Company has not declared nor paid any cash dividends on its publicly traded common stock after the completion of our IPO in October 2023. We currently intend to retain earnings and profits, if any, to support our business strategy and do not intend to pay any cash dividends within the foreseeable future. Any future determination to pay cash dividends will be at the sole discretion of our Board of Directors and will depend upon the financial condition of the Company, its operating results, capital requirements, general business conditions and any other factors that our Board of Directors deems relevant.

<div align='center'>16

PRIVATE PLACEMENT</div>

Securities Purchase Agreement

As we reported on a Form 8-K filed with the SEC
on February 5, 2025, on February 4, 2025 (the “Closing Date”) we entered into a securities purchase agreement (the “SPA”)
with the Selling Stockholder pursuant to which we agreed to issue and sell to the Selling Stockholder, upon the terms and conditions set
forth in the SPA: (i) a Senior Secured Convertible Note in the original principal amount of $5,500,000 which matures